These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34793443)

  • 21. Factors affecting human IgE and IgG responses to allergen-like Schistosoma mansoni antigens: Molecular structure and patterns of in vivo exposure.
    Fitzsimmons CM; McBeath R; Joseph S; Jones FM; Walter K; Hoffmann KF; Kariuki HC; Mwatha JK; Kimani G; Kabatereine NB; Vennervald BJ; Ouma JH; Dunne DW
    Int Arch Allergy Immunol; 2007; 142(1):40-50. PubMed ID: 17019080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human IgE responses to Schistosoma mansoni and resistance to reinfection.
    Dunne DW; Butterworth AE; Fulford AJ; Ouma JH; Sturrock RF
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():99-103. PubMed ID: 1343933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schistosoma mansoni cercarial elastase (SmCE): differences in immunogenic properties of native and recombinant forms.
    El-Faham MH; Wheatcroft-Francklow KJ; Price HP; Sayers JR; Doenhoff MJ
    Parasitology; 2017 Sep; 144(10):1356-1364. PubMed ID: 28777067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular vesicles secreted by Schistosoma mansoni contain protein vaccine candidates.
    Sotillo J; Pearson M; Potriquet J; Becker L; Pickering D; Mulvenna J; Loukas A
    Int J Parasitol; 2016 Jan; 46(1):1-5. PubMed ID: 26460238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgG4 and IgE responses to Schistosoma mansoni adult worms after treatment.
    Webster M; Fallon PG; Fulford AJ; Butterworth AE; Ouma JH; Kimani G; Dunne DW
    J Infect Dis; 1997 Feb; 175(2):493-4. PubMed ID: 9203682
    [No Abstract]   [Full Text] [Related]  

  • 26. New insights into the reaction of Schistosoma mansoni cercaria to the human complement system.
    Da'dara AA; Krautz-Peterson G
    Parasitol Res; 2014 Oct; 113(10):3685-96. PubMed ID: 25030119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SCHISTOSOMA MANSONI INFECTION AND THE ASSOCIATED ANTIBODY IMMUNE RESPONSE AMONGST RESIDENTS OF KIGUNGU ENTEBBE, UGANDA.
    Odongo-Aginya EI; Wilson RA; Kyabayinze D; Sempewo H; Oliveira RC; Kironde F
    East Afr Med J; 2012 Apr; 89(4):111-20. PubMed ID: 26856035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schistosoma mansoni schistosomula antigens induce Th1/Pro-inflammatory cytokine responses.
    Egesa M; Lubyayi L; Tukahebwa EM; Bagaya BS; Chalmers IW; Wilson S; Hokke CH; Hoffmann KF; Dunne DW; Yazdanbakhsh M; Labuda LA; Cose S
    Parasite Immunol; 2018 Dec; 40(12):e12592. PubMed ID: 30239006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.
    Cardoso FC; Pacífico RN; Mortara RA; Oliveira SC
    Clin Exp Immunol; 2006 Jun; 144(3):382-91. PubMed ID: 16734606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of recombinant calreticulin and cercarial transformation fluid (CTF) in the serodiagnosis of Schistosoma mansoni.
    El Aswad Bel D; Doenhoff MJ; El Hadidi AS; Schwaeble WJ; Lynch NJ
    Immunobiology; 2011 Mar; 216(3):379-85. PubMed ID: 20691496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
    Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
    Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the use of C-terminal part of the Schistosoma mansoni 200kDa tegumental protein in schistosomiasis diagnosis and vaccine formulation.
    Carvalho GB; Pacífico LG; Pimenta DL; Siqueira LM; Teixeira-Carvalho A; Coelho PM; Pinheiro Cda S; Fujiwara RT; Oliveira SC; Fonseca CT
    Exp Parasitol; 2014 Apr; 139():24-32. PubMed ID: 24560833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sm-p80-based vaccine trial in baboons: efficacy when mimicking natural conditions of chronic disease, praziquantel therapy, immunization, and Schistosoma mansoni re-encounter.
    Siddiqui AJ; Molehin AJ; Zhang W; Ganapathy PK; Kim E; Rojo JU; Redman WK; Sennoune SR; Sudduth J; Freeborn J; Hunter D; Kottapalli KR; Kottapalli P; Wettashinghe R; van Dam GJ; Corstjens PLAM; Papin JF; Carey D; Torben W; Ahmad G; Siddiqui AA
    Ann N Y Acad Sci; 2018 Aug; 1425(1):19-37. PubMed ID: 29888790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Schistosoma mansoni cyclophilin A epitope 107-121 induces a protective immune response against schistosomiasis.
    de Melo TT; Mendes MM; Alves CC; Carvalho GB; Fernandes VC; Pimenta DLF; de Moraes Mourão M; Gai F; Kalli M; Coelho A; de Azambuja Ribeiro RIM; Falcone FH; Pereira RADS; Fonseca CT
    Mol Immunol; 2019 Jul; 111():172-181. PubMed ID: 31063938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice.
    Yang W; Jackson DC; Zeng Q; McManus DP
    Vaccine; 2000 Aug; 19(1):103-13. PubMed ID: 10924792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A quantitative proteomic analysis of the tegumental proteins from Schistosoma mansoni schistosomula reveals novel potential therapeutic targets.
    Sotillo J; Pearson M; Becker L; Mulvenna J; Loukas A
    Int J Parasitol; 2015 Jul; 45(8):505-16. PubMed ID: 25910674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that the reduced surface antigenicity of developing Schistosoma mansoni schistosomula is due to antigen shedding rather than host molecule acquisition.
    Pearce EJ; Basch PF; Sher A
    Parasite Immunol; 1986 Jan; 8(1):79-94. PubMed ID: 2421228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of IgG1 and IgG4 subtypes reactive against potato apyrase in schistosomiasis patients.
    Faria-Pinto Pd; Mendes RG; Carvalho-Campos Cd; Maia AC; Oliveira AA; Coelho PM; Vasconcelos EG
    Mem Inst Oswaldo Cruz; 2010 Jul; 105(4):370-3. PubMed ID: 20721477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
    Farah IO; Johansson M; Lövgren-Bengtson K; Hau J
    Scand J Immunol; 2000 Mar; 51(3):237-43. PubMed ID: 10736092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.